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36978 | RSC Adv., 2016, 6, 36978–369ycols and mechanochemistry for
the preparation of bioactive 3,5-disubstituted
hydantoins†
L. Konnert, M. Dimassi, L. Gonnet, F. Lamaty, J. Martinez and E. Colacino*
Mechanochemistry was eﬀective for the preparation of 3,5-disubstituted hydantoins from a-amino methyl
esters, using either 1,10-carbonyldiimidazole (CDI) or alkyl isocyanates. The preparation of the antimicrobial
additives, 3-allyl-5,50-dimethyl hydantoin (ADMH) and 1-chloro-3-ethyl-5,50-dimethyl hydantoin (CEDMH)
were performed by grinding. A chlorination reaction, never described before by mechanochemistry was
achieved by Ca(ClO)2, while the preparation of the bioactive anticonvulsant marketed drug ethotoin was
achieved by a novel approach based on poly(ethylene) glycol (PEGs) assisted grinding.Fig. 1 Drugs with N- and/or C-disubstituted hydantoin structure.Introduction
Hydantoins or 2,4-imidazolidinediones are a well-known family
of bioactive compounds with numerous therapeutic properties.1
Among the diversity of potential structures due to the high
degree of possible substitutions of the hydantoin core, 3,5-
disubstituted hydantoins show particularly interesting biolog-
ical activities. Marketed drugs contain a hydantoin scaﬀold,
notably the anticonvulsant drug ethotoin,2 the androgen
receptor antagonist nilutamide,3 or the antimicrobial additives
for polymer textiles and medical applications 1-chloro-3-ethyl-
5,5-dimethyl hydantoin (CEDMH)4 and 3-allyl-5,50-dimethylhy-
dantoin (ADMH)5 (Fig. 1).
Various methodologies have been applied to the synthesis of
3,5-disubstituted hydantoins. A straightforward pathway is the
alkylation/arylation6–10 of the N-3 position of 5- or 5,50-disub-
stituted hydantoins but most of the procedures describe the
cyclisation of ureido derivatives of amino esters A, prepared
by reaction with isocyanates (either in solution11–17 or on solid-
support18–23) (Method A, Scheme 1), phosgene,24 or
triphosgene.25–29
We have recently demonstrated that mechanochemistry was
successfully applied to the eco-friendly preparation of 5,50-
disubstituted hydantoins,30 including the antiepileptic drug
phenytoin (Phenytek®, Fig. 1). We present herein a general and
unprecedented mechanochemical approach to access 3,5-
disubstituted hydantoins from a-amino esters, via an ureidoBMM), UMR 5247 CNRS – UM – ENSCM,
eam, Universite´ de Montpellier, Campus
llier Cedex 5, France. E-mail: evelina.
(ESI) available: General remarks,
all compounds and spectral data (1H
analyses of compounds 4. See DOI:
86derivative A (Method A, Scheme 1), obtained from the corre-
sponding isocyanate. This ureido derivative A could also be
obtained via an original route, from N-carbamoyl imidazole
activated amino ester derivative B (Method B, Scheme 1), by
reaction with various amines. Molecules such as 1-chloro-3-
ethyl-5,5-dimethyl hydantoin (CEDMH),4 3-allyl-5,50-dime-
thylhydantoin (AMDH)5 and the anticonvulsant drug ethotoin
were synthesized. An unprecedented mechanochemical chlori-
nation reaction was achieved with Ca(ClO)2 with better results
when compared with solution syntheses. In the case of ethotoin,
three synthetic strategies have been explored in a ball-mill (BM),
including the poly(ethylene) glycols-assisted grinding
approach,31,32 applied for the rst time to access Active Phar-
maceutical Ingredients (API).Scheme 1 Possible routes to 3,5-disubstituted hydantoins via ureido
derivatives of amino esters.
This journal is © The Royal Society of Chemistry 2016
Table 2 Preparation of 3,5-disubstituted hydantoins following
Method B and Method A
R1 R2 Product
Yielda,b (%)
Bc A
d
NCe RCe NCe
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View Article OnlineResults and discussion
The mechanochemical preparation of 3-ethyl-5-benzyl hydan-
toin 2 was rst investigated, according to a one-pot/two step
procedure based on Method B (Scheme 1). Phenylalanine
methyl ester hydrochloride was reacted with CDI in a planetary
ball-mill (PBM), leading to the corresponding 1H-imidazole-
carboxamido derivative 1 (Table 1). Milling the mixture in the
presence of ethylamine hydrochloride – added in the second
step – resulted in the unsymmetrical urea 3 that was converted
into the hydantoin 2 by base-mediated intramolecular cycliza-
tion, using stoichiometric amounts of solid K2CO3. Selected
data for the optimization of the reaction conditions are reported
in Table 1.
In the rst trial (entry 1), the starting amino ester was not
fully converted into the intermediate 1 and a symmetrical urea
species of phenylalanine methyl ester was formed, resulting in
a reduced yield (65%) of the desired product 3-ethyl-5-benzyl-
hydantoin 2. Results were not improved when the milling
speed was increased to 750 rpm (66%) or by adding ethylamine
hydrochloride in excess (64%). Extending the reaction time
during the rst step (entry 2) resulted in a lower yield (52%) of 2,
due to the formation of increased amounts of symmetrical urea.
This trend was also observed when adding either CDI or amino
ester portion-wise and seemed to be emphasized when CDI was
present in excess (entries 1 and 2). When the amount of CDI was
decreased (1.3 equiv.) and the number of balls in the jar wasTable 1 Screening of the conditions for the preparation of 3-ethyl-5-
benzyl hydantoin 2 (Method B)a
Entry CDI (equiv.) Balls (n)
Conditions (min)
Yieldb (%)Step 1 Step 2
1 2 25 10 120 65
2 2 25 60 120 52
3 1.3 50 40 60 84
4 1.3 50 60, 8  (50/20)c 60 77
5 1.1 50 60, 8  (50/20)c 120 67
6 1.3 50 40, EtOAcd 120 75
a The reactions were performed in a stainless steel jar (using stainless
steel balls, 5 mm B) at 450 rpm under continuous milling except
when otherwise stated. b Isolated yields. c (x0/y0): the reaction mixture
was cycle-milled for 40 minutes during 8 cycles of 5 minutes followed
by 2 minute standby, with reverse rotation between two cycles. d 400
mL (h ¼ 0.37 mL mg1) of EtOAc were added.
This journal is © The Royal Society of Chemistry 2016doubled (50), aer precipitation in water, hydantoin 2 was ob-
tained in a better yield (84%, entry 3). Neither cycled
milling30,33,34 (entries 4 and 5) nor decreasing the amount of CDI
(entry 5) or Liquid-Assisted Grinding (LAG) with ethyl acetate
(entry 6), improved the yield of the reaction.
The reaction was investigated with other combinations of a-
amino esters/amines (Table 2, Method B). Both allyl and ben-
zylamine reacted smoothly with phenylalanine imidazole-
carboxamido derivative 1 aﬀording the corresponding hydan-
toins (13 and 18 respectively) in good yields. The reactivity of the
system was not inuenced by the physical state (solid or liquid)
of the amine as also conrmed by leucine (compounds 4 and
19) and aminoisobutyric (Aib) methyl ester (compounds 11 and
16). However, it seemed that the steric and electronic nature of
the entering amine drove the outcome of the reaction.
Indeed, hydantoin 24 was obtained in moderate yield (49%)
when cyclohexylamine (c-Hex-NH2) was tested, while no reac-
tion was observed in the presence of the sterically hinderedCH2Ph CH2CH3 2
f 84 n.p.g 75
CH2CH(CH3)2 CH2CH3 4 61(70)
h 76(70)h 83(90)h
CH2Ph(p-O
tBu) CH2CH3 5 56 82 82
(CH2)4NHCbz CH2CH3 6 31 61 n.p.
g
CH2CH2SCH3 CH2CH3 7 40 57 78
CH(CH3)CH2CH3 CH2CH3 8 67 58 84
CH2O
tBu CH2CH3 9 51 64 98
CH2SCH2Ph CH2CH3 10 38 50 61
CH3/CH3
i CH2CH3 11 61 62 79
Ph CH2CH3 12 34 40 35
CH2Ph CH2CH]CH2 13 75 n.p.
g n.p.g
CH2CH(CH3)2 CH2CH]CH2 14 57 58 n.p.
g
CH(CH3)O
tBu CH2CH]CH2 15 51 66 n.p.
g
CH3/CH3
i CH2CH]CH2 16 46 65 n.p.
g
Ph/Phi CH2CH]CH2 17 25 n.p.
g n.p.g
CH2Ph CH2Ph 18 70 n.p.
g 85
CH2CH(CH3)2 CH2Ph 19 38 74 67
CH2Ph Ph 20 n.p.
g 0 n.p.g
CH2O
tBu Ph 21 n.p.g n.p.g 30
CH2Ph CH(CH3)2 22 n.p.
g n.p.g 0(93)j
CH2Ph(p-O
tBu) CH(CH3)2 23 n.p.
g 0 n.p.g
CH2Ph(p-O
tBu) c-Hex 24 n.p.g 49k n.p.g
a Isolated yields. b L-a-Amino esters were used except when otherwise
stated. c Conditions: (step 1) a-amino ester (1 equiv.) and CDI (1.3
equiv.) at 450 rpm, 50 balls (5 mm, stainless steel, 5 mm B) for 40
min, (step 2) R2NH2 (1.6 equiv.) and K2CO3 (3.6 equiv.) at 450 rpm for
2 hours. d a-Amino ester (1 equiv.) R2NCO (3.0 equiv.) and K2CO3 (3.0
equiv.) at 30 Hz for 2 hours, 2 balls (5 mm, stainless steel, 5 mm B).
e NC ¼ not crystallized, RC ¼ recrystallized. f Residual metals were
analyzed by ICP-MS (see Experimental part). g Not performed. h The
reaction was performed adding PEG-2000-(OMe)2 (455 mg mmol
1
substrate). i Quaternary a-amino ester HCl$H-Aib-OMe or HCl$H-
Gly(Ph)2-OMe were used.
j Yield reported within brackets is given for
the ureido intermediate. k 1H NMR yield using CH2Br2 (20 mL) as
internal reference.
RSC Adv., 2016, 6, 36978–36986 | 36979
Scheme 2 Mechanochemical routes to CEDMH 25 and 26.
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View Article Onlineisopropylamine, or the less reactive and poorly nucleophilic
aniline. These results suggested that the limiting step was the
formation of the corresponding ureido intermediate (rst step).
Surprisingly, the yield of the reaction dropped with an a-amino
ester component other than phenylalanine. Presuming that the
diﬀerence in crystalline structure was the reason for this drop in
the yield, the starting amino methyl esters were recrystallized to
remove potential impurities.
Aer recrystallization, most of the desired hydantoins were
obtained in much better yields (except for compound 8) espe-
cially in the case of compounds 5, 6, 10, 19. It can be hypoth-
esized that the crystalline state and the steric and electronic
nature of side chains of starting a-amino esters drive the
mechanochemical reactivity. Indeed, similar side chains
(compounds 2/5, 8/4 and 9/15) led to similar yields. Electroni-
cally rich a-amino esters, such as phenylglycine or diphenyl-
glycine showed a moderate reactivity (12 and 17 respectively),
while sterically hindered quaternary aminoisobutyric (Aib)
methyl ester showed, as previously observed,30,33 good reactivity
in mechanochemical processes (11 and 16), leading straight-
forwardly to 3-allyl-5,50-dimethylhydantoin (ADMH, Fig. 1) 16
with a satisfying yield.
Overall, the mechanochemical preparation of CDI-mediated
3,5-disubstituted hydantoins is an environmentally friendly
approach. The products were readily obtained from an easy-to-
handle procedure, using cheap and commercially available
substrates and reactants, allowing versatility of substituents in
both C-5 and N-3 hydantoin ring positions. In most cases, the
products were recovered by precipitation in water, the only side-
products present in the reaction mixture being the non-toxic
water-soluble imidazole, CO2 and inorganic salts. When
precipitation of the expected compound was not possible,
extraction with ethyl acetate and benign 10% aqueous citric
acid35 was performed.
Mechanochemical preparation of 3,5-disubstituted hydan-
toins was also investigated using alkyl or aryl isocyanates
(Method A, Scheme 1), for the sake of comparison and to
provide an alternative route when Method B led to moderate
yields. By grinding the a-amino ester, the isocyanate and the
potassium carbonate, a cascade reaction sequence occurred,
involving formation of the ureido derivative A, followed by in
situ cyclization into hydantoins, with high atom economy
(Scheme 1). In the case of benzyl hydantoin 2, no diﬀerence was
observed when changing the jar material (stainless steel or
tungsten carbide) or under diﬀerent mechanical stress provided
by a vibrational (VBM) or planetary (PBM) ball-mill (see Table S1
in ESI†). Vibrational ball-mill and stainless steel jars were used
to prepare 3,5-disubstituted hydantoins, readily obtained in
good to excellent yields, with generally improved results
compared to the CDI-mediated Method B (Table 2).
It is worth noting here that isopropylisocyanate reacted
smoothly with phenylalanine methyl ester, leading to the cor-
responding ureido derivative in high yield (93%). Cyclization
was not observed, probably hampered by the steric hindrance
around the nitrogen atom.
The study was completed by measuring the concentration of
residual metals aer ball-milling in the stainless-steel jar for36980 | RSC Adv., 2016, 6, 36978–36986compound 4 (see Experimental section). The organic product
contamination was far below the threshold level of permitted
daily exposures and uptake for elemental impurities in human.
Overall, the two methods are a valuable alternative to solution
syntheses, providing new or already commercialized
compounds (see Table S2 in ESI†).
Method A was eﬀective to access 3-ethyl-5,50-dimethyl
hydantoin (EDMH) 11 in good yield (79%), that was further
transformed into the textile antimicrobial additive5 1-chloro-3-
ethyl-5,50-dimethylhydantoin (CEDMH) 25. A chlorination
reaction using mechanochemistry – never described before –
was performed in the planetary ball-mill using the swimming
pool safe chlorinating agent trichloroisocyanuric acid (TCCA),
which furnished 25 in 34% yield, similar to the synthesis in
solution (Scheme 2). Better results were obtained when calcium
hypochlorite was used: not only was compound 25 obtained in
the very good yield of 87%, but the crude product was cleaner,
generating only calcium salts as waste. This chlorination
approach is a valuable and more powerful alternative to the use
of TCCA either in solution or by grinding and it was successfully
applied (99% yield) also to the preparation of compound 26,
with high chemioselectivity, with the allyl moiety unreactive in
these conditions (Scheme 2).
Synthesis of 3-ethyl-5-phenyl hydantoin (ethotoin, 12)
The preparation of ethotoin in solution is restricted to only two
publications,36,37 involving either cyclization of 5-ethyl-2-
phenylhydantoic acid36 or rearrangement of ethyl N-Boc-phe-
nylglycinamide37 (70% and 60% yield respectively) under
anhydrous conditions, both strongly acid-catalyzed conditions.
N-3-alkylation of 5-phenylhydantoin, prepared by mechano-
chemistry following our previously described procedure,30
remained unsuccessful in ball-milling conditions, or neat under
stirring, even with a large excess of alkyl halide. The N-alkyl-
ation (Method C) was improved when poly(ethylene) glycol (HO-
PEG-400-OH) was used as the reaction solvent (entry 1, Table 3):
ethotoin 12 was obtained in a 40% yield, a similar result to the
previous methods A and B.
Poly(ethylene) glycols are green solvents38 with low toxicity,
nding applications in the biomedical eld39 and catalysis.40
Very recently, their peculiar role was highlighted in metal-This journal is © The Royal Society of Chemistry 2016
Table 3 PEG-assisted grinding: three alternative synthetic routes to ethotoin 12
Entry Methoda RO-PEG-OR (av. MW) Conditions Yieldb (%)
1 Ac — 30 Hz 2 h or 450 rpm, 40/120 min 35
2 B — 450 rpm, 40/120 min 40
3 C — Stirring, rt, neat Traces
4 C HO-400-OH Stirring, rt, overnight 40d
5 C HO-3400-OH 300 rpm, 6  (15/2)e 45
6 C HO-2000-OH 300 rpm, 6  (15/2)e 20
7 C MeO-2000-OMe 300 rpm, 6  (15/2)e 20
8 B MeO-2000-OMe 450 rpm, 40/120 min 65
9 A MeO-2000-OMe 450 rpm, 120 min 63
a
L-Phenylglycine methyl ester was used; PEG (455 mg mmol1 substrate) was added in each experiment. b Isolated yields. c Both vibrational (VBM)
and planetary (PBM) ball-mill were tested. d Determined by NMR. e The reaction medium was ground for 6 cycles of 15 min with 2 min pauses in
between, with reverse rotation.
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View Article Onlinecatalyzed processes in a ball-mill32 or by ultrasounds,41 having
in common similar activation eﬀects,42 or in Polymer-Assisted
Grinding (POLAG) processes for co-crystal formation.31
Considering the preliminary result indicating that PEG
polymer seemed to improve the eﬃciency of N-alkylation, the
conditions were transposed to a ball-milled reaction (Table 3).
Using solid HO-PEG-3400-OH (entry 5) in the mechanochemical
conditions produced ethotoin 12 in 45% yield, compared with
only traces when carried out under neat conditions (entry 3).
The combination of mechanochemical forces and PEG matrix
proved to be benecial for N-alkylation when other approaches
failed. Comparing several poly(ethylene) glycols (entries 5–7), it
can be assumed that the length of the polymer might have an
inuence on the physical interactions of the system, more than
its chemical composition.31 This suggests that the system would
require a specic ‘polymer catalyst’ to be found, in agreement
with the fact that mechanochemical forces can alter reaction
pathways of synthetic polymers.43 In light of these results, MeO-
PEG-2000-OMe was selected to grind the mixture (Table 3,
entries 8 and 9) in the case of methods A and B, to avoid
potential side reactions of HO-PEG-3400-OH end terminal
hydroxyl groups with ethyl isocyanate or CDI.
As presumed, the mechanochemical productivity in the
presence of a PEG matrix was increased as the reactions were by
far more eﬃcient. 3-Ethyl-5-phenylhydantoin 12 was obtained
in much higher yield from both methods (Table 3, entries 8 and
9) compared with grinding in the absence of additives (Tables 2
and 3 entries 2 and 3).
It was reported that solid dispersion of ethotoin 12 in PEG
solvent displayed improved solubility and diﬀusion proper-
ties.44 At a molecular level, this was explained by the existence of
hydrogen bonding NH/O between the amide and the polyetherThis journal is © The Royal Society of Chemistry 2016chain.45 Similar interactions can be evoked with 5-phenyl
hydantoin30 (Method C) or ureido derivative A (Methods A and
B). In this case, liquid-assisted grinding would be responsible
for the enhanced mechanochemical productivity observed for
all the methods. However, POLAG cannot be excluded, not only
because the existence of interactions with PEG polymers are
known to induce changes in the physical state of the system,45
especially under mechanochemical stress,31 but also because
PEG polymers act as a chelation matrix of potassium cations, as
a result of its crown-ether-like eﬀect.38 The direct consequence
is that both reactivity and solubility of ‘naked’ CO3
2 counter
ions under mechanochemical activation could be enhanced in
the presence of PEG catalyst. Thus, two diﬀerent eﬀects acting
in synergy and at diﬀerent stages of the reaction mechanism
could be responsible for the enhanced reactivity of the system in
PEG: (i) improved solubility of reactants, reaction intermediates
and nal product; (ii) chelation eﬀect of potassium cation (from
K2CO3).
In view of these results, the PEG additive was also tested for
preparation of compound 4 by using CDI- or isocyanate-based
methods (Table 2). In the presence of MeO-PEG-2000-OMe,
the yield was 70% when following Method B (27%) – indepen-
dently of the crystalline state of the starting material – and
slightly improved when following Method A (90%), however the
recovery of the nal pure product was more complicated.
Instead of precipitation by water (when PEG was not used),
liquid–liquid extraction and PEG-precipitation were needed,
hampering the easiness of recovery and lessening the positive
environmental impact of the methodology.
Compound 4 was analyzed to assess the chiral integrity for
both A and B methods (Table 4). Chiral HPLC analyses (see
ESI†) for compound 4 showed complete loss of enantiopurity.RSC Adv., 2016, 6, 36978–36986 | 36981
Table 4 Assessment of chirality for PEG-assisted grinding to
compound 4
Method
Without PEG With PEGa
erb (%) eeb (%) erb (%) eeb (%)
A 53/47 3 63/37 26
B 53/47 3 83/17 66
a MeO-PEG-2000-OMe (455 mg mmol1 substrate) was added in each
experiment. b Reaction performed from L-H-Leu-OMe: er: L/D.
RSC Advances Paper
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View Article OnlineThis might be due to the formation of ‘high concentration’ of
potassium methanolate during cyclisation. However, the addi-
tion of MeO-PEG-2000-OMe proved to be benecial, partially
preserving the enantiopurity, probably because of the dilution
eﬀect of the medium. To the best of our knowledge, this is the
rst example showing that PEG-assisted grinding helped to
retain optical purity to a certain extent. This unexpected
behaviour deserves further investigations.Conclusions
We described herein two mechanochemical routes to access
diverse 3,5-disubstituted hydantoins from cheap and readily
available a-amino esters, either by reaction with isocyanates or
by activation of the N-terminal position with CDI. The versatility
of these procedures allowed us to prepare bactericide mono-
mers or additives for polymer textiles such as 3-allyl-5,50-dime-
thylhydantoin (ADMH) 16 and 1-chloro-3-ethyl-5,50-
dimethylhydantoin (CEDMH) 25, obtained with highly
increased yield compared with solution synthesis using
Ca(ClO)2 as the chlorinating agent. Three novel and eﬃcient
procedures based on mechanochemistry and using poly-
oxygenated PEG solvents provided easy access to the anticon-
vulsant ethotoin 12 in good yields, with no use of strong base or
acid and for which very few literature was available. Moreover,
the use of a green solvent such as PEG has the advantage of
being non-toxic, non-ammable and non-volatile, unlike
solvents oen used for LAG (ethyl acetate, nitromethane). The
ball-mill technology aﬀorded easily handling and mild reaction
conditions and PEG solvents were applicable for all methods (A,
B and C) where grinding without an additive failed. However,
further detailed studies are needed to elucidate the mechanistic
aspects of this process when PEG is used. This would also shed
light on its role in optical purity preservation during milling,
never investigated before. It is worth noticing that the drug
examples prepared here are either achiral or racemic, so the loss
of chirality does not aﬀect their preparation, even in the
absence of the PEG additive.
The two mechanochemical methods herein described
(Methods A and B) are a valuable alternative to solution
synthesis to access to 3,5-dialkylhydantoins, but they were not
suitable for the preparation of 3-aryl-5-alkyl hydantoin such as
ethotoin 12, except when PEG was used. They have allowed the
preparation of a library of hydantoins, some of which are36982 | RSC Adv., 2016, 6, 36978–36986already commercialized but whose synthesis has still not been
divulged, but most have not been reported in the literature.
Experimental section
Method A
(Table 2, compounds 2, 4, 5, 7–12, 18–19 and 21) – Vibrational
Ball Mill (VBM). The a-amino methyl ester (1.0 equiv.), alkyl
isocyanate (3.0 equiv.) and K2CO3 (3.0 equiv.) were ground in
a vibrational ball-mill at 30 Hz for 2 hours. Distilled water was
added to the reaction mixture and the desired compound was
precipitated and ltered over sintered glass, or extracted with
ethyl acetate. The organic layer was washed with 10% aq. citric
acid (3) and brine (1), dried on MgSO4 and concentrated.
Flash chromatography, normal or reverse phase, was performed
on the crude sample.
Only for compound 12 (Table 3) – Planetary Ball Mill (PBM): in
the case of PEG-assisted grinding the reaction was performed by
adding MeO-PEG-2000-OMe (455 mg mmol1 substrate), in
a planetary ball-mill, at 450 rpm for 2 hours using 50 balls (5
mm diameter). The compound was recovered by extraction with
ethyl acetate aer addition of distilled water to the reaction
mixture. The organic layer was washed with 10% aq. citric acid
and brine, dried over MgSO4 and concentrated. The compound
was puried by ash chromatography (linear gradient of EtOAc
in cyclohexane: 0–80%).
Method B
(Table 2, compounds 2, 4, 5-19 and 24) – Planetary Ball Mill
(PBM). The a-amino methyl ester (1.0 equiv.) and 1,10-carbon-
ylimidazole (CDI) (1.3 equiv.) were ground in a 12 mL stainless
steel milling jar in a planetary ball-mill at 450 rpm for 40
minutes using 50 balls (5 mm diameter). The amine (1.6 equiv.)
and K2CO3 (3.6 equiv.) were added and the mixture was ground
at 450 rpm for two hours. Distilled water was added to the crude
and the desired compound was precipitated and ltered over
sintered glass, or extracted with ethyl acetate. The organic layer
was washed with 10% aq. citric acid (3) and brine (1), dried
on MgSO4 and concentrated. Flash chromatography, normal or
reverse phase, was performed on the crude sample.
Only for compound 12 (Table 3): in the case of PEG-assisted
grinding the reaction was performed adding MeO-PEG-2000-
OMe (455 mg mmol1 substrate). The compound was recov-
ered by extraction with ethyl acetate aer addition of distilled
water to the reaction mixture. The organic layer was washed
with 10% aq. citric acid and brine, dried over MgSO4 and
concentrated. The compound was puried by ash chroma-
tography (linear gradient of EtOAc in cyclohexane: 0–80%).
Method C
(Table 3, compound 12). 5-Phenylhydantoin30 (50 mg, 1.0
equiv.), ethyl bromide (106.0 mL, 5.0 equiv.) and K2CO3 (40 mg
1.0 equiv.) were milled with HO-PEG-3400-OH (455 mg mmol1
substrate) in a planetary ball-mill at 300 rpm for 6 cycles of 15
minutes with 2 minute pauses in between. Distilled water was
added to the reaction mixture and the aqueous phase wasThis journal is © The Royal Society of Chemistry 2016
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View Article Onlineextracted with ethyl acetate. The organic layer was washed 10%
aq. citric acid (3) and brine (1), dried on MgSO4 and
concentrated. Preparative TLC (cyclohexane: EtOAc 60 : 40 v/v)
was performed on the crude sample.
3-Ethyl-5-benzylimidazolidine-2,4-dione 2 (Table 2). CAS
[158500-83-5]. The reaction scale was: 0.20 mmol (for VBM) or
1.16 mmol (for PBM). The compound was obtained by precipi-
tation in water (Method A: 32.6 mg, 75% yield, Method B: 211.6
mg, 84% yield). White solid, mp 116–117 C; IR (cm1): 3278
(NH), 3065, 2970, 2930, 1758 (C]O), 1693, 1605 (C]O), 1496,
1462, 1427, 1380, 1227, 1194, 1981, 1095, 1069, 1009, 919, 934,
859, 786, 765, 755, 748, 696, 679; 1H NMR (300 MHz, CDCl3)46
d (ppm): 7.32–7.18 (m, 5H, ArH), 5.87 (s, 1H, NH), 4.23–4.20 (m,
1H, C-5/CH), 3.51–3.43 (m, 2H, CH2), 3.23 (dd, J ¼ 13.9 and J ¼
3.4, 1H, CH2/HA), 2.88 (dd, J ¼ 13.9 and J ¼ 8.1, 1H, CH2/HB),
1.06 (t, J ¼ 7.1, 3H, CH3); 13C NMR (300 MHz, CDCl3) d (ppm):
172.9, 157.0, 135.1, 129.3, 128.8, 127.4, 58.2, 37.9, 33.5, 13.2; MS
ESI-(+): m/z 219 [M + H]+.
ICP-MS data. Concentration of residual metal aer ball-
milling in the stainless steel jar. Quantity of sample analyzed:
50 mg.Method CThis journr [ppb]
M
[al is © Thn
ppb]e Royal SFe [ppb]ociety of CNi
[ppb]hemistryCu
[ppb]
C
[2016d
ppb]W
[ppb]A
(VBM)
28 736.1 1871.0 224714.1 1736.5 1047.7 61.2 3.9B
(PBM)
38 846.9 1561.1 219276.2 889.4 2200.6 12.6 26.73-Ethyl-5-isobutylimidazolidine-2,4-dione 4 (Table 2). The
reaction scale was: 0.20 mmol (for VBM) or 1.05 mmol (for
PBM). The compound was obtained by precipitation in water
(Method A: 30.4 mg, 83% yield; Method B: 147.1 mg, 76% yield).
White solid, mp 116–117 C; IR (cm1): 3226, 3098 (NH), 2962,
2940, 2876, 1760 (C]O), 1697 (C]O), 1450, 1423, 1350, 1314,
1256, 1216, 1147, 1092, 1007, 873, 841, 783, 764, 709; 1H NMR
(300 MHz, CDCl3) d (ppm): 5.74 (s, 1H, NH), 4.01 (m, 1H, C-5/
CH), 3.55 (q, J ¼ 7.1, 2H, CH2), 1.79 (m, 2H, CH2), 1.51 (m,
1H, CH), 1.21 (t, J ¼ 7.2, 3H, CH3), 0.97 (m, 6H, CH3); 13C NMR
(300 MHz, CDCl3) d (ppm): 174.4, 157.6, 55.9, 41.0, 33.7, 25.4,
23.2, 21.8, 13.5; MS ESI-(+): m/z 185 [M + H]+; HRMS ESI-(+):
calcd for C9H17N2O2 [M + H]
+ 185.1290, found 185.1292.
3-Ethyl-5-[(4-tert-butoxy)-phenylmethyl]-imidazolidine-2,4-
dione 5 (Table 2). The reaction scale was: 0.22 mmol (for VBM)
or 0.95 mmol (for PBM). The compound was obtained by
precipitation in water (Method A: 225.1 mg, 82% yield; Method
B: 52.0 mg, 82% yield). White solid, mp 123–125 C; IR (cm1):
3258 (NH), 2971, 2933, 1761 (C]O), 1698 (C]O), 1609, 1507,
1426, 1353, 1257 (C(CH3)3), 1222 (C(CH3)3), 1179, 1161, 1104,
897, 877, 840, 761, 707; 1H NMR (300 MHz, CDCl3) d (ppm): 7.08
(d, J ¼ 8.2, 2H, ArH3,5), 6.93 (d, J ¼ 8.2, 2H, ArH2,6), 5.39 (s, 1H,
NH), 4.19 (m, 1H, C-5/CH), 3.48 (m, 2H, CH2), 3.20 (dd, J ¼ 13.9
and J¼ 3.3, 1H, CH2/HA), 2.83 (dd, J¼ 13.8 and J¼ 8.2, 1H, CH2/
HB), 1.32 (s, 9H, OC(CH3)3), 1.08 (t, J ¼ 7.1, 3H, CH3); 13C NMR
(300 MHz, CDCl3) d (ppm): 173.1, 157.0, 155.0, 130.0, 124.6,
78.8, 58.4, 37.4, 33.7, 29.0, 13.4; MS ESI-(+): m/z 291 [M + H]+,235 [(M  tBu) + H]+; HRMS ESI-(+): calcd for C16H22N2O3 [M +
Na]+ 313.1528, found 313.1526.
Benzyl 4-(1-ethyl-2,5-dioxoimidazolidin-4-yl)-butylcarbamate
6 (Table 2). The reaction scale was: 0.86 mmol (for PBM). The
compound was puried by ash chromatography (linear
gradient of EtOAc in cyclohexane: 0–80%); (Method B: 173.8 mg,
61% yield). White solid, mp 92–94 C; IR (cm1): 3309, 3221
(NH), 3100, 2926, 2860, 1765 (C]O), 1686 (C]O), 1540, 1463,
1436, 1272, 1141, 1108, 1026, 796, 765, 691; 1H NMR (300 MHz,
DMSO-d6) d (ppm): 8.19 (s, 1H, NH), 7.36–7.23 (m, 6H, ArH), 5.00
(s, 2H, OCH2), 4.02–3.99 (m, 1H, C-5/CH), 3.38–3.34 (m, 2H,
CH2), 2.96 (q, J¼ 6.0, 2H, CH2), 1.67–1.23 (m, 6H, (CH2)3), 1.05 (t,
J ¼ 7.1, 3H, CH3); 13C NMR (300 MHz, DMSO-d6) d (ppm): 174.1,
156.7, 156.1, 137.3, 128.4, 127.7, 65.1, 56.1, 32.5, 30.9, 21.3, 13.3;
MS ESI-(+):m/z 334 [M + H]+, 290, 226, 356 [M + Na]+. HRMS ESI-
(+): calcd for C17H23N3O4 [M + H]
+ 334.1767, found 334.1765.
3-Ethyl-5-[2-(methylthio)ethyl]imidazolidine-2,4-dione 7
(Table 2). CAS [1218137-72-4]. The reaction scale was: 0.20
mmol (for VBM) or 1.03 mmol (for PBM). The compound was
puried by ash chromatography (linear gradient of EtOAc in
cyclohexane: 0–80%); (Method A: 31.6 mg, 78% yield, Method B:
118.3 mg, 57% yield). Pale yellow solid, mp 82–84 C; IR (cm1):
3447, 3295 (NH), 2981, 2933, 1759 (C]O), 1684 (C]O), 455,
1422, 1353, 1288, 1218, 1174, 1106, 1007, 999, 967; 833, 765,
708; 1H NMR (300 MHz, CDCl3) d (ppm): 6.01 (s, 1H, NH), 4.14
(m, 1H, C-5/CH), 3.56 (q, J ¼ 6.8, 2H, CH2), 2.64 (m, 2H, CH2),
2.29–2.20 (m, 1H, CH2/HA), 2.11 (s, 3H, SCH3), 2.00–1.88 (m, 1H,
CH2/HB), 1.21 (t, J ¼ 6.8, 3H, CH3); 13C NMR (300 MHz, CDCl3)
d (ppm): 173.7, 157.4, 56.6, 33.8, 30.7, 30.5, 15.4, 13.5; MS ESI-
(+): m/z 203 [M + H]+, 174, 155. HRMS ESI-(+): calcd for
C8H14N2O2S [M + H]
+ 203.0854, found 203.0849.
3-Ethyl-5-(sec-butyl)-imidazolidine-2,4-dione 8 (Table 2). CAS
[1218012-31-7]. The reaction scale was: 0.20 mmol (for VBM) or
1.05 mmol (for PBM). The compound was obtained by precipi-
tation in water (Method A: 30.8 mg, 84% yield; Method B: 112.4
mg, 58% yield). Colourless oil. IR (cm1): 3243 (NH), 2965, 2877,
1765 (C]O), 1693 (C]O), 1451, 1425, 1350, 1214, 1121, 1003,
956, 903, 764, 708; 1H NMR (300 MHz, DMSO-d6) d (ppm): 8.15
(s, 1H, NH), 4.01 (m, 1H, C-5/CH), 3.39–3.35 (m, 2H, CH2), 1.80–
1.76 (m, 1H, CH), 1.37–1.11 (m, 1H, CH2/HA), 1.04 (t, J¼ 7.1, 3H,
CH3), 0.90–0.68 (m, 10H, CH3 and CH2/HB);
13C NMR (300 MHz,
DMSO-d6) d (ppm) (1 : 1 mixture of diastereoisomers): 173.9,
173.5, 157.2, 156.9, 60.8, 59.6, 38.7, 36.4, 36.1, 32.4, 25.5, 23.3,
14.9, 13.3, 12.9, 11.6; MS ESI-(+): m/z 185 [M + H]+; HRMS ESI-
(+): calcd for C9H17N2O2 [M + H]
+ 185.1290, found 185.1288.
3-Ethyl-5-(tert-butoxymethyl)-imidazolidine-2,4-dione 9
(Table 2). The reaction scale was: 0.20 mmol (for VBM) or 1.02
mmol (for PBM). The compound was puried by ash chro-
matography (linear gradient of EtOAc in cyclohexane: 0–
80%); (Method A: 42.1 mg, 98% yield; Method B: 139.0 mg,
64% yield). White solid, mp 119–121 C; IR (cm1): 3304
(NH), 2971, 2933, 1764 (C]O), 1698 (C]O), 1460, 1430, 1359,
1234 (C(CH3)3), 1213 (C(CH3)3), 1195, 1119, 1100, 1069, 887,
810, 755, 707, 676; 1H NMR (300 MHz, CDCl3) d (ppm): 5.74 (s,
1H, NH), 4.10 (dd, J ¼ 7.5 and J ¼ 2.9, 1H, C-5/CH), 3.74 (dd, J
¼ 9.2 and J ¼ 3.0, 1H, CH2/HA), 3.59–3.44 (m, 3H, CH2/HB and
CH2), 1.23–1.17 (m, 13H, CH3 and OC(CH3)3);
13C NMR (300RSC Adv., 2016, 6, 36978–36986 | 36983
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View Article OnlineMHz, CDCl3) d (ppm): 171.9, 157.5, 74.1, 62.0, 58.1, 33.8, 27.5,
13.5; MS ESI-(+): m/z 185 [M + H]+; HRMS ESI-(+): calcd for
C8H18N3O3 [M + H]
+ 215.0668, found 215.0670.
5-(Benzylthiomethyl)-3-ethylimidazolidine-2,4-dione 10
(Table 2). The reaction scale was: 0.18 mmol (for VBM) or 0.97
mmol (for PBM). No further purication aer work-up was
needed. (Method A: 28.9 mg, 61% yield; Method B: 128.0 mg,
50% yield). White solid, mp 96–98 C; IR (cm1): 3221 (NH)
3098, 2968, 2917, 1757 (C]O), 1700 (C]O), 1451, 1405, 1346,
1237, 1216, 1115, 999, 878, 813, 776, 730, 693; 1H NMR (300
MHz, DMSO-d6) d (ppm): 8.29 (s, 1H, NH), 7.31–7.24 (m, 5H,
ArH), 4.35 (sbroad, 1H, C-5/CH), 3.77 (s, 2H, SCH2), 3.40–3.37 (m,
2H, CH2), 2.76 (m, 2H, CH2), 1.08 (t, J ¼ 7.1, 3H, CH3); 13C NMR
(300 MHz, DMSO-d6) d (ppm): 172.9, 156.8, 138.2, 128.9, 128.4,
127.0, 56.3, 36.0, 32.7, 32.1, 13.3; MS ESI-(+): m/z 265 [M + H]+.
HRMS ESI-(+): calcd for C13H16N2O2S [M + H]
+ 265.1011, found
265.1007.
3-Ethyl-5,50-dimethyl-2,4-imidazolidinedione 11 (Table 2).
CAS [37021-15-1]. The reaction scale was: 0.21 mmol (for VBM)
or 1.08 mmol (for PBM). No further purication aer work-up
was needed. (Method A: 25.8 mg, 79% yield; Method B: 104.5
mg, 62% yield). White solid, mp 72–74 C (lit.5 96 C); IR (cm1):
3212 (NH), 3099, 2980, 2937, 1766 (C]O), 1700 (C]O), 1449,
1420, 1349, 1285, 1204, 1180, 1094, 1067, 936, 879, 751, 705; 1H
NMR (300 MHz, DMSO-d6) d (ppm): 8.22 (s, 1H, NH), 3.39–3.32
(m, 2H, CH2), 1.26 (s, 6H, CH3), 1.06 (t, J ¼ 7.1, 3H, CH3); 13C
NMR (300 MHz, DMSO-d6) d (ppm): 177.6, 155.7, 58.0, 33.0,
25.0, 13.7; MS ESI-(+): m/z 157.0 [M + H]+; HRMS ESI-(+): calcd
for C7H12N2O2 [M + H]
+ 157.0977, found 157.0978.
3-Ethyl-5-phenyl-2,4-imidazolidinedione 12 (Table 3). CAS
[86-35-1]48. The reaction scale was: 1.24 mmol (for Method A) or
0.92 mmol (for Method B). No further purication aer work-up
was needed. Yields given are referred to PEG-assisted grinding.
(Method A: 160.5 mg, 63%; Method B: 121.8 mg, 65% yield;
Method C: 25.8 mg, 45%). White solid, mp 86–88 C (the
synthesis was previously published but melting point36,37 was
not reported); IR (cm1): 3320 (NH), 2982, 2945, 1762 (C]O),
1691 (C]O); 1454, 1427, 1340, 1288, 1211, 1179, 1080, 1002,
824, 760, 701; 1H NMR (300MHz, DMSO-d6) d (ppm): 8.68 (s, 1H,
NH), 7.43–7.31 (m, 5H, ArH), 5.19 (s, 1H, C-5/CH), 3.40 (qd, J ¼
7.0 and J ¼ 1.7, 2H, CH2), 1.08 (t, J ¼ 7.1, 3H, CH3); 13C NMR
(300 MHz, DMSO-d6) d (ppm): 172.0, 157.7, 134.5, 129.3, 129.2,
126.6, 60.8, 34.0, 31.0, 13.5; MS ESI-(+): m/z 205 [M + H]+.
3-Allyl-5-benzyl-2,4-imidazolidinedione 13 (Table 2). CAS
[160448-61-3]. The reaction scale was: 1.16 mmol (for PBM). The
compound was obtained by precipitation in water; (Method B:
197.9 mg, 75% yield). White solid, mp 116–118 C; IR (cm1):
3447, 3341 (NH), 3031, 2927, 1767 (C]O), 1698 (C]O), 1496,
1450, 1418, 1359, 1312, 1254, 1207, 1119, 1000, 937, 915, 752,
738, 702, 669, 654; 1H NMR (300 MHz, DMSO-d6) d (ppm): 8.28
(s, 1H, NH), 7.26–7.15 (m, 5H, ArH), 5.48 (td, J ¼ 10.8 and J ¼
5.2, 1H, CHallyl), 4.86 (d, J¼ 10.3, 1H, CH2allyl/Hcis), 4.54 (d, J¼
17.3, 1H, CH2allyl/Htrans), 4.44–4.42 (m, 1H, C-5/CH), 3.84–3.69
(m, 2H, CH2), 2.98 (d, J ¼ 3.3, 2H, CH2); 13C NMR (300 MHz,
DMSO-d6) d (ppm): 173.0, 156.1, 135.2, 131.8, 129.8, 128.1,
126.7, 115.6, 57.1, 36.3; MS ESI-(+):m/z 231 [M + H]+; HRMS ESI-
(+): calcd for C13H14N2O2 [M + H]
+ 231.1134, found 231.1134.36984 | RSC Adv., 2016, 6, 36978–369863-Allyl-5-isobutylimidazolidine-2,4-dione 14 (Table 2). CAS
[51112-67-5]. The reaction scale was: 1.19 mmol (for PBM). The
compound was puried by ash chromatography (linear
gradient of EtOAc in cyclohexane: 0–80%); (Method B: 110.5 mg,
58% yield). White solid, mp 95–97 C; IR (cm1): 3221 (NH),
3099, 2955, 2871, 1676 (C]O), 1708 (C]O) 1647, 1451, 1410,
1371, 1359, 1336, 1207, 1155, 996, 929, 875, 731, 693, 661; 1H
NMR (300 MHz, CDCl3) d (ppm): 5.85–5.76 (m, 2H, NH and
CHallyl), 5.30–5.18 (m, 2H, CH2allyl), 4.11–4.05 (m, 3H, C-5/CH
and CH2), 1.81–1.79 (m, 2H, CH2), 1.60–1.42 (m, 1H, CH), 0.98
(t, J ¼ 4.4, 3H, CH3); 13C NMR (300 MHz, CDCl3) d (ppm): 174.2,
157.3, 131.2, 118.1, 56.0, 41.1, 40.7, 25.4, 23.2, 21.8; MS ESI-(+):
m/z 197 [M + H]+, 169.0; HRMS ESI-(+): calcd for C10H16N2O2 [M
+ H]+ 197.1290, found 197.1292.
3-Allyl-5-[1-(tert-butoxy)-ethyl]-imidazolidine-2,4-dione 15
(Table 2). The reaction scale was: 1.14 mmol (for PBM). The
compound was puried by ash chromatography (linear
gradient of EtOAc in cyclohexane: 0–80%); (Method B: 181.9 mg,
66% yield). White solid, mp 51–53 C; IR (cm1): 3300 (NH),
2975, 2935, 1753 (C]O), 1697 (C]O), 1648, 1556, 1451
(C(CH3)3), 1415 (C(CH3)3), 1363, 1191, 1123, 1078, 969, 923, 771,
734; 1H NMR (300 MHz, DMSO-d6) d (ppm) (3 : 1 mixture of
diastereoisomers): 8.19 (2  s, 1H, NH), 5.80–5.67 (m, 1H,
CHallyl), 5.14–5.05 (m, 2H, CH2allyl), 4.03–3.90 (m, 4H, C-5/CH,
OCH and CH2), 1.19–1.05 (m, 12H, CH3 and OC(CH3));
13C NMR
(300 MHz, DMSO-d6) d (ppm) (3 : 1 mixture of diastereoiso-
mers): 172.8, 172.2, 157.4, 157.1, 132.8, 132.7, 121.7, 116.6,
116.3, 74.2, 73.8, 67.6, 66.1, 63.2, 62.0, 28.8, 28.6, 20.9, 18.5; MS
ESI-(+): m/z 241 [M + H]+, 185.0; HRMS ESI-(+): calcd for
C12H20N2O3 [M + H]
+ 241.1552, found 241.1554.
3-Allyl-5,5-dimethylimidazolidine-2,4-dione 16 (Table 2).
CAS [158500-83-5]. The reaction scale was: 1.23 mmol (for PBM).
The compound was puried by ash chromatography (linear
gradient of EtOAc in cyclohexane: 0–80%); (Method B: 134.3 mg,
65% yield). Colourless oil. IR (cm1): 3460, 3326 (NH), 3090, 2979,
2937, 2879, 1760 (C]O), 1690 (C]O), 1645, 1527, 1444, 1393,
1329, 1265, 1178, 1015, 972, 916, 874, 777, 733; 1H NMR (300
MHz, CDCl3)47 d (ppm): 5.93 (sbroad, 1H, NH), 5.90–5.77 (m, 1H,
CHallyl), 5.20 (dq, J ¼ 6.5 and J ¼ 1.4, 1H, CH2allyl/Hcis), 5.17 (t, J
¼ 1.4, 1H, CH2allyl/Htrans), 4.09 (dt, J ¼ 5.5 and J ¼ 1.5, 2H, CH2),
1.45 (s, 6H, CH3);
13C NMR (300 MHz, CDCl3) d (ppm): 177.0,
156.2, 131.3, 117.7, 59.0, 40.6, 25.2; MS ESI-(+): m/z 241 [M + H]+.
3-Allyl-5,5-diphenylimidazolidine-2,4-dione 17 (Table 2). CAS
[160448-65-7]. The reaction scale was: 0.67 mmol (for PBM). The
compound was obtained by precipitation in water; (Method B:
49.8 mg, 25% yield). White solid, mp 121–123 C (lit.48 114–117
C); IR (cm1): 3262 (NH), 3091, 2982, 1770, 1749 (C]O), 1709
(C]O), 1494, 1467, 1393, 1240, 1182, 1117, 1024, 801, 736, 702,
664; 1H NMR (300 MHz, CDCl3)47 d (ppm): 7.36 (s, 10H, ArH),
6.29 (s, 1H, NH), 5.85 (qt, J ¼ 10.2 and J ¼ 5.6, 1H, CHallyl), 5.23
(dq, J ¼ 11.2 and J ¼ 1.5, 1H, CH2allyl/Hcis), 5.19–5.17 (m, 1H,
CH2allyl/Htrans), 4.18 (dt, J ¼ 5.7 and J ¼ 1.5, 2H, CH2); 13C NMR
(300 MHz, CDCl3) d (ppm): 173.0, 156.1, 139.3, 131.0, 129.0,
128.8, 127.0, 70.3, 41.1; MS ESI-(+): m/z 293.0 [M + H]+, 265.0.
3,5-Dibenzylimidazolidine-2,4-dione 18 (Table 2). CAS [2221-
11-6]. The reaction scale was: 0.17mmol (for VBM) or 1.07mmolThis journal is © The Royal Society of Chemistry 2016
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View Article Online(for PBM). The compound was obtained by precipitation in
water; (Method A: 40.5 mg 85% yield; Method B: 210.7 mg, 70%
yield). White solid, mp 137–139 C (lit.49 153–154 C 49 and 145–
146 50); IR (cm1): 3347, 3295 (NH), 3062, 3031, 2927, 1760 (C]
O), 1695 (C]O), 1604, 1495, 1447, 1419, 1362, 1341, 116, 1251,
1183, 1140, 1026, 965, 930, 877, 753, 716, 669; 1H NMR (300
MHz, DMSO-d6)48 d (ppm): 8.36 (s, 1H, NH), 7.25–7.17 (m, 8H,
ArH), 6.78–6.76 (m, 2H, ArH), 4.50 (t, J ¼ 4.5, 1H, C-5/CH), 4.36
(q, J ¼ 18.5, 2H, CH2), 3.00 (d, J ¼ 4.7, 2H, CH2); 13C NMR (300
MHz, DMSO-d6) d (ppm): 173.2, 156.2, 136.3, 135.0, 129.9, 128.3,
128.1, 126.9, 126.8, 126.5, 57.2, 40.7, 36.1; MS ESI-(+): m/z 281.0
[M + H]+.
3-Benzyl-5-isobutylimidazolidine-2,4-dione 19 (Table 2). The
reaction scale was: 0.18 mmol (for VBM) or 1.09 mmol (for PBM).
The compound was puried by ash chromatography (linear
gradient of EtOAc in cyclohexane: 0–80%); CAS [880487-34-3]
(Method A: 29.5 mg, 67% yield; Method B: 197.1 mg, 74%
yield). White solid, mp 114–116 C (lit. 79–80 C); IR (cm1): 3223
(NH), 3106, 2960, 2872, 1764 (C]O), 1709 (C]O), 1448, 1415,
1348, 1334, 1209, 1153, 936, 891, 879, 763, 721, 658; 1H NMR (300
MHz, DMSO-d6)51 d (ppm): 8.41 (s, 1H, NH), 7.33–7.22 (m, 5H,
ArH), 4.51 (s, 2H, CH2), 4.17–4.13 (s, 1H, C-5/CH), 1.84–1.71 (m,
1H, CH), 1.58–1.35 (m, 2H, CH2), 0.89–0.86 (m, 6H, CH3);
13CNMR
(300 MHz, DMSO-d6) d (ppm): 174.6, 156.6, 136.8, 128.5, 127.3,
55.0, 41.0, 40.8, 24.1, 23.1, 21.4; MS ESI-(+): m/z 247 [M + H]+.
3-Phenyl-5-(tert-butoxymethyl)-imidazolidine-2,4-dione 21
(Table 2). The reaction scale was: 0.17 mmol (for VBM). The
compound was puried by ash chromatography (linear
gradient of EtOAc in cyclohexane: 0–40%); 13.4 mg, 30% yield.
White solid, mp 101–103 C; IR (cm1): 3326 (NH), 2970, 2919,
2850, 1783, 1708, 1597, 1494, 1414, 1363, 1336, 1284, 1237
(C(CH3)3), 1184, 1100, 1086, 1011, 931, 818, 737, 704, 689;
1H
NMR (300 MHz, CDCl3) d (ppm): 7.53–7.31 (m, 5H, ArH), 5.94 (s,
1H, NH), 4.29 (m, 1H, C-5/CH), 3.82 (dd, J ¼ 9.2 and J ¼ 3.1, 1H,
CH2/HA), 3.65 (dd, J ¼ 9.2 and J ¼ 6.9, 1H, CH2/HB), 1.20 (s, 9H,
OC(CH3)3);
13C NMR (300 MHz, CDCl3) d (ppm): 171.1, 156.7,
131.6, 129.3, 128.4, 126.4, 74.2, 61.9, 58.1, 27.5; MS ESI-(+): m/z
263 [M + H]+, 207; HRMS ESI-(+): calcd for C14H18N2O3 [M + H]
+
263.1396, found 263.1392.
3-Cyclohexyl-5-(4-tert-butoxybenzyl)-imidazolidine-2,4-dione
24 (Table 2). The reaction scale was: 0.43 mmol (for PBM). 120.2
mg, 50% yield (1H NMR yield using dibromomethane (20 mL) as
internal standard). 1H NMR (300 MHz, CDCl3) d (ppm): 7.08 (d, J
¼ 4.5 Hz, 2H, ArH3,5), 6.92 (d, J¼ 4.5 Hz, 2H, ArH2,6), 5.24 (s, 1H,
NH), 4.17–4.07 (m, 1H, C-5/CH), 3.86–3.71 (m, 1H, CH), 3.15
(dd, J ¼ 14.0 and J ¼ 3.8, 1H, CH2/HA), 2.85 (dd, J ¼ 14.0 and J ¼
7.8, 1H, CH2/HB), 1.90–1.08 (m, 19H, CH2cyclohexyl and
OC(CH3));
13C NMR (300 MHz, CDCl3) d (ppm): 173.2, 157.2,
130.1, 129.8, 125.1, 124.6, 78.7, 57.6, 51.5, 37.4, 29.4, 29.2, 28.9,
26.0, 25.1; HRMS ESI-(+): calcd for C20H28N2O3 [M + H]
+
345.2178, found 345.2177.
1-Chloro-3-ethyl-5,50-dimethyl-2,4-imidazolidinedione 25
(Scheme 2)
Chlorination with TCCA. 3-Ethyl-5,50-dimethyl-2,4-
imidazolidinedione 11 (98 mg, 0.63 mmol) and tri-
chloroisocyanuric acid (TCCA) (73 mg, 0.31 mmol) were placed
into a 12 mL stainless steel jar with 25 stainless steel millingThis journal is © The Royal Society of Chemistry 2016balls (5 mm diameter) and milled for 15 minutes at 300 rpm.
Water was then added to the reaction medium and the aqueous
layer was extracted with ethyl acetate. The organic layer was
washed with 10% aq. citric acid and brine, dried over anhydrous
MgSO4 and concentrated. The crude was puried by column
chromatography (linear gradient of EtOAc in cyclohexane: 0–
60%) aﬀording 25 as white crystals (41 mg, 34% yield).
Chlorination with calcium hypochlorite. 3-Ethyl-5,50-dimethyl-
2,4-imidazolidinedione 11 (101 mg, 0.65 mmol) and calcium
hypochlorite (185 mg, 1.29 mmol) were placed into a 12 mL
stainless steel jar with 50 stainless steel milling balls (5 mm
diameter) and milled for one hour at 450 rpm. Dichloro-
methane was added to the reaction medium. The precipitated
inorganic salts were ltered over sintered glass and the ltrate
was concentrated to yield 25 as a white solid (107 mg, 87%
yield). Mp 72–74 C (lit.5 96.6 C); CAS [886757-26-2];5 IR (cm1):
3468, 3231, 2983 (NH), 2938, 1770 (C]O); 1700 (C]O); 1442,
1411, 1379, 1341, 1293, 1229, 1208, 1161, 1067, 1001, 943, 881,
833, 757, 729; 1H NMR (300 MHz, CDCl3)48 d (ppm): 3.61 (q, J ¼
7.2, 2H, CH2), 1.45 (s, 6H, CH3), 1.22 (t, J ¼ 7.2, 3H, CH3); 13C
NMR (300 MHz, CDCl3) d (ppm): 174.3, 154.7, 65.9, 34.9, 22.3,
13.5; MS ESI-(+): m/z for 35Cl/37Cl 191/193 [M + H]+; HRMS ESI-
(+): calcd for C7H11N2O2Cl [M + H]
+ 191.0587, found 191.0587.
1-Chloro-3-allyl-5,50-dimethyl-2,4-imidazolidinedione 26
(Scheme 2). Chlorination was performed with calcium hypo-
chlorite starting from 3-allyl-5,5-dimethylimidazolidine-2,4-
dione 16. The reaction scale was 0.179 mmol. The nal
product was recovered by precipitation (0.181 mg, 99% yield), as
previously described for compound 25. CAS [1174756-67-2].
White solid, mp 68–70 C; IR (cm1): 3471, 3099 (NH), 2995,
2940, 1774 (C]O), 1714 (C]O), 1648, 1413, 1398, 1327, 1226,
1165, 1135, 944, 912, 876, 824, 758, 728; 1H NMR (300 MHz,
CDCl3) d (ppm): 5.88–5.75 (m, 1H, CHallyl), 5.27–5.25, 5.25–5.23
(m  2, 1H, CH2allyl/Hcis), 5.21–5.19 (m, 1H, CH2allyl/Htrans),
4.15 (dt, J ¼ 6, 2H, CH2), 1.47 (s, 6H, 2  CH3); 13C NMR (300
MHz, CDCl3) d (ppm): 174.2, 130.8, 119.0, 66.2, 41.9, 22.5; MS
ESI-(+): m/z for 35Cl/37Cl 203/205, 175, 169, 130; HRMS ESI-(+):
calcd for C8H12N2O2Cl [M + H]
+ 203.0587, found 203.0589.
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